Long-Term Outcomes of Patients With BRCA+ or PALB2+ Pancreatic Cancer Treated With Maintenance Rucaparib: A Secondary Analysis of a Nonrandomized Clinical Trial.
Saved in:
| Title: | Long-Term Outcomes of Patients With BRCA+ or PALB2+ Pancreatic Cancer Treated With Maintenance Rucaparib: A Secondary Analysis of a Nonrandomized Clinical Trial. |
|---|---|
| Authors: | Reiss KA; Abramson Cancer Center, University of Pennsylvania, Philadelphia.; Department of Medicine, Division of Medical Oncology, University of Pennsylvania, Philadelphia., Xia M; Abramson Cancer Center, University of Pennsylvania, Philadelphia.; Department of Medicine, Division of Translational Medicine and Human Genetics, University of Pennsylvania, Philadelphia., Akamandisa M; Abramson Cancer Center, University of Pennsylvania, Philadelphia.; Department of Medicine, Division of Translational Medicine and Human Genetics, University of Pennsylvania, Philadelphia.; Department of Genetics, Yale University, New Haven, Connecticut., D'Andrea K; Abramson Cancer Center, University of Pennsylvania, Philadelphia.; Department of Medicine, Division of Translational Medicine and Human Genetics, University of Pennsylvania, Philadelphia., Wubbenhorst B; Abramson Cancer Center, University of Pennsylvania, Philadelphia.; Department of Medicine, Division of Translational Medicine and Human Genetics, University of Pennsylvania, Philadelphia., Lord CJ; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK., Pettitt SJ; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK., Tutt ANJ; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK., Brown TJ; Abramson Cancer Center, University of Pennsylvania, Philadelphia.; Department of Medicine, Division of Medical Oncology, University of Pennsylvania, Philadelphia.; Department of Medicine, Division of Hematology/Oncology, University of Texas Southwestern, Dallas., O'Hara MH; Abramson Cancer Center, University of Pennsylvania, Philadelphia.; Department of Medicine, Division of Medical Oncology, University of Pennsylvania, Philadelphia., Schneider C; Abramson Cancer Center, University of Pennsylvania, Philadelphia.; Department of Medicine, Division of Medical Oncology, University of Pennsylvania, Philadelphia., Teitelbaum U; Abramson Cancer Center, University of Pennsylvania, Philadelphia.; Department of Medicine, Division of Medical Oncology, University of Pennsylvania, Philadelphia., Hannan Z; Abramson Cancer Center, University of Pennsylvania, Philadelphia.; Department of Medicine, Division of Medical Oncology, University of Pennsylvania, Philadelphia.; Internal Medicine Residency Program, Main Line Health System, Philadelphia, Pennsylvania., Hood R; Abramson Cancer Center, University of Pennsylvania, Philadelphia.; Department of Medicine, Division of Medical Oncology, University of Pennsylvania, Philadelphia.; Miller School of Medicine, University of Miami, Miami, Florida., Tondon R; Abramson Cancer Center, University of Pennsylvania, Philadelphia.; Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia., Vonderheide RH; Abramson Cancer Center, University of Pennsylvania, Philadelphia.; Department of Medicine, Division of Medical Oncology, University of Pennsylvania, Philadelphia., Domchek SM; Abramson Cancer Center, University of Pennsylvania, Philadelphia.; Department of Medicine, Division of Medical Oncology, University of Pennsylvania, Philadelphia.; The Basser Center for BRCA, University of Pennsylvania, Philadelphia., Nathanson KL; Abramson Cancer Center, University of Pennsylvania, Philadelphia.; Department of Medicine, Division of Translational Medicine and Human Genetics, University of Pennsylvania, Philadelphia.; The Basser Center for BRCA, University of Pennsylvania, Philadelphia. |
| Source: | JAMA oncology [JAMA Oncol] 2026 Jun 01; Vol. 12 (6), pp. 666-670. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Medical Association Country of Publication: United States NLM ID: 101652861 Publication Model: Print Cited Medium: Internet ISSN: 2374-2445 (Electronic) Linking ISSN: 23742437 NLM ISO Abbreviation: JAMA Oncol Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42060271 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Long-Term Outcomes of Patients With BRCA+ or PALB2+ Pancreatic Cancer Treated With Maintenance Rucaparib: A Secondary Analysis of a Nonrandomized Clinical Trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Reiss+KA%22">Reiss KA</searchLink>; Abramson Cancer Center, University of Pennsylvania, Philadelphia.; Department of Medicine, Division of Medical Oncology, University of Pennsylvania, Philadelphia.<br /><searchLink fieldCode="AU" term="%22Xia+M%22">Xia M</searchLink>; Abramson Cancer Center, University of Pennsylvania, Philadelphia.; Department of Medicine, Division of Translational Medicine and Human Genetics, University of Pennsylvania, Philadelphia.<br /><searchLink fieldCode="AU" term="%22Akamandisa+M%22">Akamandisa M</searchLink>; Abramson Cancer Center, University of Pennsylvania, Philadelphia.; Department of Medicine, Division of Translational Medicine and Human Genetics, University of Pennsylvania, Philadelphia.; Department of Genetics, Yale University, New Haven, Connecticut.<br /><searchLink fieldCode="AU" term="%22D'Andrea+K%22">D'Andrea K</searchLink>; Abramson Cancer Center, University of Pennsylvania, Philadelphia.; Department of Medicine, Division of Translational Medicine and Human Genetics, University of Pennsylvania, Philadelphia.<br /><searchLink fieldCode="AU" term="%22Wubbenhorst+B%22">Wubbenhorst B</searchLink>; Abramson Cancer Center, University of Pennsylvania, Philadelphia.; Department of Medicine, Division of Translational Medicine and Human Genetics, University of Pennsylvania, Philadelphia.<br /><searchLink fieldCode="AU" term="%22Lord+CJ%22">Lord CJ</searchLink>; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK.<br /><searchLink fieldCode="AU" term="%22Pettitt+SJ%22">Pettitt SJ</searchLink>; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK.<br /><searchLink fieldCode="AU" term="%22Tutt+ANJ%22">Tutt ANJ</searchLink>; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK.<br /><searchLink fieldCode="AU" term="%22Brown+TJ%22">Brown TJ</searchLink>; Abramson Cancer Center, University of Pennsylvania, Philadelphia.; Department of Medicine, Division of Medical Oncology, University of Pennsylvania, Philadelphia.; Department of Medicine, Division of Hematology/Oncology, University of Texas Southwestern, Dallas.<br /><searchLink fieldCode="AU" term="%22O'Hara+MH%22">O'Hara MH</searchLink>; Abramson Cancer Center, University of Pennsylvania, Philadelphia.; Department of Medicine, Division of Medical Oncology, University of Pennsylvania, Philadelphia.<br /><searchLink fieldCode="AU" term="%22Schneider+C%22">Schneider C</searchLink>; Abramson Cancer Center, University of Pennsylvania, Philadelphia.; Department of Medicine, Division of Medical Oncology, University of Pennsylvania, Philadelphia.<br /><searchLink fieldCode="AU" term="%22Teitelbaum+U%22">Teitelbaum U</searchLink>; Abramson Cancer Center, University of Pennsylvania, Philadelphia.; Department of Medicine, Division of Medical Oncology, University of Pennsylvania, Philadelphia.<br /><searchLink fieldCode="AU" term="%22Hannan+Z%22">Hannan Z</searchLink>; Abramson Cancer Center, University of Pennsylvania, Philadelphia.; Department of Medicine, Division of Medical Oncology, University of Pennsylvania, Philadelphia.; Internal Medicine Residency Program, Main Line Health System, Philadelphia, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Hood+R%22">Hood R</searchLink>; Abramson Cancer Center, University of Pennsylvania, Philadelphia.; Department of Medicine, Division of Medical Oncology, University of Pennsylvania, Philadelphia.; Miller School of Medicine, University of Miami, Miami, Florida.<br /><searchLink fieldCode="AU" term="%22Tondon+R%22">Tondon R</searchLink>; Abramson Cancer Center, University of Pennsylvania, Philadelphia.; Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia.<br /><searchLink fieldCode="AU" term="%22Vonderheide+RH%22">Vonderheide RH</searchLink>; Abramson Cancer Center, University of Pennsylvania, Philadelphia.; Department of Medicine, Division of Medical Oncology, University of Pennsylvania, Philadelphia.<br /><searchLink fieldCode="AU" term="%22Domchek+SM%22">Domchek SM</searchLink>; Abramson Cancer Center, University of Pennsylvania, Philadelphia.; Department of Medicine, Division of Medical Oncology, University of Pennsylvania, Philadelphia.; The Basser Center for BRCA, University of Pennsylvania, Philadelphia.<br /><searchLink fieldCode="AU" term="%22Nathanson+KL%22">Nathanson KL</searchLink>; Abramson Cancer Center, University of Pennsylvania, Philadelphia.; Department of Medicine, Division of Translational Medicine and Human Genetics, University of Pennsylvania, Philadelphia.; The Basser Center for BRCA, University of Pennsylvania, Philadelphia. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101652861%22">JAMA oncology</searchLink> [JAMA Oncol] 2026 Jun 01; Vol. 12 (6), pp. 666-670. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Medical+Association%22">American Medical Association </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101652861 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2374-2445 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223742437%22">23742437 </searchLink><i>NLM ISO Abbreviation: </i>JAMA Oncol <i>Subsets: </i>MEDLINE; In Process |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42060271 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1001/jamaoncol.2026.0870 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 666 Titles: – TitleFull: Long-Term Outcomes of Patients With BRCA+ or PALB2+ Pancreatic Cancer Treated With Maintenance Rucaparib: A Secondary Analysis of a Nonrandomized Clinical Trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Reiss KA – PersonEntity: Name: NameFull: Xia M – PersonEntity: Name: NameFull: Akamandisa M – PersonEntity: Name: NameFull: D'Andrea K – PersonEntity: Name: NameFull: Wubbenhorst B – PersonEntity: Name: NameFull: Lord CJ – PersonEntity: Name: NameFull: Pettitt SJ – PersonEntity: Name: NameFull: Tutt ANJ – PersonEntity: Name: NameFull: Brown TJ – PersonEntity: Name: NameFull: O'Hara MH – PersonEntity: Name: NameFull: Schneider C – PersonEntity: Name: NameFull: Teitelbaum U – PersonEntity: Name: NameFull: Hannan Z – PersonEntity: Name: NameFull: Hood R – PersonEntity: Name: NameFull: Tondon R – PersonEntity: Name: NameFull: Vonderheide RH – PersonEntity: Name: NameFull: Domchek SM – PersonEntity: Name: NameFull: Nathanson KL IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 06 Text: 2026 Jun 01 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 2374-2445 Numbering: – Type: volume Value: 12 – Type: issue Value: 6 Titles: – TitleFull: JAMA oncology Type: main |
| ResultId | 1 |